Problems in type II diabetic patients developing insulin requirement

[1] MANAGEMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN EUROPE - A CONSENSUS VIEW [J]. DIABETIC MEDICINE, 1988, 5 (03) : 275 - 281

[2] THE EFFICACY OF ACARBOSE IN THE TREATMENT OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - A MULTICENTER CONTROLLED CLINICAL-TRIAL [J]. ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) : 928 - 935

[3] EASTMAN RC, 1994, DIABETES REV, V2, P263

[4] TREATMENT OF NIDDM WITH INSULIN AGONISTS OR SUBSTITUTES [J]. DIABETES CARE, 1990, 13 (12) : 1209 - 1239

[5] THE EFFECT OF INSULIN-TREATMENT ON INSULIN-SECRETION AND INSULIN ACTION IN TYPE-II DIABETES-MELLITUS [J]. DIABETES, 1985, 34 (03) : 222 - 234

[6] MANAGEMENT OF THE ADULT-ONSET DIABETIC WITH SULFONYLUREA DRUG FAILURE [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1992, 21 (02) : 351 - 370

[7] GROOP L, 1989, AM J MED, V87, P183

[8] REMISSION OF INSULIN REQUIREMENT IN LATE SECONDARY FAILURE TO ORAL HYPOGLYCEMIC AGENTS (IRD) - RESULTS AT 24 MONTHS AND ANALYSIS OF PREDICTIVE FACTORS [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1991, 13 (03) : 189 - 198

[9] STUDY OF THE RATE OF EARLY GLUCOSE DISAPPEARANCE FOLLOWING INSULIN INJECTION - INSULIN SENSITIVITY INDEX [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 20 (03) : 201 - 207

[10] SUBCUTANEOUS INJECTION OF THE INCRETIN HORMONE GLUCAGON-LIKE PEPTIDE-1 ABOLISHES POSTPRANDIAL GLYCEMIA IN NIDDM [J]. DIABETES CARE, 1994, 17 (09) : 1039 - 1044

[1] MANAGEMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN EUROPE - A CONSENSUS VIEW [J]. DIABETIC MEDICINE, 1988, 5 (03) : 275 - 281

[2] THE EFFICACY OF ACARBOSE IN THE TREATMENT OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - A MULTICENTER CONTROLLED CLINICAL-TRIAL [J]. ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) : 928 - 935

[3] EASTMAN RC, 1994, DIABETES REV, V2, P263

[4] TREATMENT OF NIDDM WITH INSULIN AGONISTS OR SUBSTITUTES [J]. DIABETES CARE, 1990, 13 (12) : 1209 - 1239

[5] THE EFFECT OF INSULIN-TREATMENT ON INSULIN-SECRETION AND INSULIN ACTION IN TYPE-II DIABETES-MELLITUS [J]. DIABETES, 1985, 34 (03) : 222 - 234

[6] MANAGEMENT OF THE ADULT-ONSET DIABETIC WITH SULFONYLUREA DRUG FAILURE [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1992, 21 (02) : 351 - 370

[7] GROOP L, 1989, AM J MED, V87, P183

[8] REMISSION OF INSULIN REQUIREMENT IN LATE SECONDARY FAILURE TO ORAL HYPOGLYCEMIC AGENTS (IRD) - RESULTS AT 24 MONTHS AND ANALYSIS OF PREDICTIVE FACTORS [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1991, 13 (03) : 189 - 198

[9] STUDY OF THE RATE OF EARLY GLUCOSE DISAPPEARANCE FOLLOWING INSULIN INJECTION - INSULIN SENSITIVITY INDEX [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 20 (03) : 201 - 207

[10] SUBCUTANEOUS INJECTION OF THE INCRETIN HORMONE GLUCAGON-LIKE PEPTIDE-1 ABOLISHES POSTPRANDIAL GLYCEMIA IN NIDDM [J]. DIABETES CARE, 1994, 17 (09) : 1039 - 1044